NEW YORK – The European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Autolus Therapeutics' autologous CD19-directed CAR T-cell therapy Aucatzyl ...

A TikTok post for the "McMigraine" remedy -- Coca-Cola and a large order of fries -- caused some people to rush to McDonald's for headache relief, but this combination is not a cure or an effective ...

AstraZeneca AZN announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) rendered ...

Tevimbra is currently approved in the EU as a treatment for gastric cancer, esophageal squamous cell cancer and small cell ...

BeiGene's Tevimbra gets a highly sought after recommendation.

AstraZeneca (AZN) stock in focus as its antibody drug Imfinzi gains EU panel support for treating muscle-invasive bladder ...

Chemotherapy has been the standard treatment for metastatic NPC; however, distant metastasis continues to be a significant cause of treatment failure and death, making new treatment options essential, ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

(Alliance News) - AstraZeneca PLC on Tuesday said its Imfinzi, or durvalumab, therapy has been recommended for approval in the EU for the treatment of muscle-invasive bladder cancer.

The relentless hunger and associated behaviours significantly impact the quality of life for those with Prader-Willi syndrome ...

The two active substances are antivirals that inhibit HIV reverse transcriptase through incorporation into the viral DNA, ...

Adding Blenrep to standard therapy prolonged progression-free survival in patients with relapsed or refractory multiple ...